Revvity Inc. $RVTY Stock Holdings Reduced by Hsbc Holdings PLC

Hsbc Holdings PLC reduced its position in Revvity Inc. (NYSE:RVTY) by 26.1% during the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 184,648 shares of the company’s stock after selling 65,374 shares during the period. Hsbc Holdings PLC owned about 0.17% of Revvity worth $17,904,000 at the end of the most recent quarter.

A number of other hedge funds and other institutional investors also recently made changes to their positions in the company. AQR Capital Management LLC increased its holdings in Revvity by 5.2% in the first quarter. AQR Capital Management LLC now owns 8,449 shares of the company’s stock worth $883,000 after buying an additional 420 shares during the last quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. lifted its stake in Revvity by 6.7% in the first quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 11,776 shares of the company’s stock valued at $1,246,000 after acquiring an additional 744 shares during the last quarter. Millennium Management LLC grew its position in Revvity by 102.0% in the first quarter. Millennium Management LLC now owns 69,401 shares of the company’s stock worth $7,343,000 after acquiring an additional 35,048 shares in the last quarter. Goldman Sachs Group Inc. grew its position in Revvity by 45.5% in the first quarter. Goldman Sachs Group Inc. now owns 607,104 shares of the company’s stock worth $64,232,000 after acquiring an additional 189,871 shares in the last quarter. Finally, Focus Partners Wealth increased its stake in shares of Revvity by 13.0% during the 1st quarter. Focus Partners Wealth now owns 7,028 shares of the company’s stock worth $744,000 after purchasing an additional 811 shares during the last quarter. 86.65% of the stock is owned by hedge funds and other institutional investors.

Revvity Price Performance

Shares of Revvity stock opened at $113.60 on Friday. The firm has a fifty day simple moving average of $97.06 and a 200-day simple moving average of $97.64. The company has a current ratio of 1.72, a quick ratio of 1.41 and a debt-to-equity ratio of 0.37. Revvity Inc. has a 1-year low of $81.22 and a 1-year high of $118.30. The stock has a market capitalization of $12.67 billion, a price-to-earnings ratio of 54.35, a PEG ratio of 2.31 and a beta of 1.11.

Revvity (NYSE:RVTY) last posted its quarterly earnings data on Tuesday, May 5th. The company reported $1.06 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.02 by $0.04. The business had revenue of $711.12 million during the quarter, compared to the consensus estimate of $704.07 million. Revvity had a net margin of 8.26% and a return on equity of 8.00%. Revvity’s quarterly revenue was up 7.0% compared to the same quarter last year. During the same period in the prior year, the firm earned $1.01 EPS. Revvity has set its FY 2026 guidance at 5.200-5.300 EPS. On average, sell-side analysts expect that Revvity Inc. will post 5.25 earnings per share for the current year.

Revvity Dividend Announcement

The company also recently declared a quarterly dividend, which will be paid on Friday, August 7th. Shareholders of record on Friday, July 17th will be issued a dividend of $0.07 per share. This represents a $0.28 dividend on an annualized basis and a yield of 0.2%. The ex-dividend date is Friday, July 17th. Revvity’s dividend payout ratio is 13.40%.

Analyst Upgrades and Downgrades

A number of research analysts have recently weighed in on RVTY shares. TD Cowen raised their price target on shares of Revvity from $115.00 to $120.00 and gave the company a “buy” rating in a report on Wednesday, May 6th. Wolfe Research started coverage on shares of Revvity in a report on Tuesday, June 2nd. They issued a “peer perform” rating for the company. Stifel Nicolaus lowered their target price on shares of Revvity from $110.00 to $100.00 and set a “hold” rating on the stock in a research report on Wednesday, May 6th. Barclays raised their target price on Revvity from $95.00 to $105.00 and gave the company an “equal weight” rating in a report on Thursday, May 7th. Finally, Weiss Ratings upgraded Revvity from a “sell (d)” rating to a “sell (d+)” rating in a research note on Wednesday. Four equities research analysts have rated the stock with a Buy rating, nine have issued a Hold rating and one has issued a Sell rating to the company’s stock. According to MarketBeat.com, the stock currently has an average rating of “Hold” and a consensus target price of $107.73.

Revvity Company Profile

Revvity, Inc is a global provider of technology-enabled solutions for the life sciences, diagnostics and applied markets. The company develops and supplies a range of products and services, including reagents and consumables, laboratory instruments, workflow automation, software analytics and technical support. Its portfolio supports applications in drug discovery, genomics, cell biology research, environmental and food safety testing, industrial quality control and clinical diagnostics.

Tracing its heritage to Perkin-Elmer, founded in 1937, Revvity began trading on the New York Stock Exchange under the ticker symbol RVTY in January 2024 following a corporate rebranding.